Cooper Consumer Health in the news
European selfcare platform
Tamtam found 20 recent articles about Cooper Consumer Health.
- Stada considers acquisition of Cooper Consumer Health - Bloomberg
Stada is exploring a potential €6 billion acquisition of Cooper Consumer Health, a European self-care platform owned by CVC Capital Partners.
- Cooper And Dr Reddy’s Take Charge Of Nicotinell In Key European Markets
Cooper and Dr Reddy’s have taken charge of Nicotinell in major European markets, highlighting shifts in consumer health.
- Cooper prend la main sur la distribution de Nicotinell en France
Cooper Consumer Health took exclusive distribution of Nicotinell in France in December 2025, aiming to expand smoking cessation support through pharmacies amid growing public health efforts.
- Cooper Consumer Health se lance dans les pays nordiques
Cooper Consumer Health has partnered with Conaxess Trade to distribute and market its OTC products in Nordic countries starting March 2025.
- France: Cooper Consumer Health completes acquisition of Viatris OTC business
Cooper Consumer Health has acquired Viatris' OTC business, doubling its size in European consumer healthcare.
- Viatris completes divestitures with closing of OTC business divestiture
Viatris finalized the sale of its OTC business to Cooper Consumer Health, completing its major divestitures to streamline operations and focus on growth.
- Viatris closes $3.37bn divestitures with OTC deal
Viatris sold its entire OTC business to Cooper Consumer Health for $3.37 billion, retaining key drug rights and focusing on future growth and shareholder returns.
- Viatris closes divestiture of its OTC business
Viatris sold its OTC business to Cooper Consumer Health, a European OTC drug maker, on July 3.
- Cooper Consumer Health SAS a finalisé l'acquisition de la quasi-totalité des activités de vente libre de Viatris Inc. (NasdaqGS:VTRS).
Cooper Consumer Health SAS completed a 2.1 billion euro acquisition of Viatris's OTC business in July 2024, financed by equity and debt and subject to regulatory approvals.
- Stibbe advises Viatris in sale of substantially all of Viatris’ European OTC Business to Cooper Consumer Health
Viatris is selling most of its European OTC business to Cooper Consumer Health, with Stibbe advising on EU regulatory approvals, aiming to complete by July 2024.
- EC approves Cooper’s acquisition of Viatris’ European OTC business
The European Commission approved Cooper Consumer Health's $2.17bn acquisition of Viatris' European OTC business after Cooper agreed to divest certain product rights to maintain market competition.
- Cooper Consumer Health gets conditional EU approval to buy Viatris OTC business
Cooper Consumer Health got conditional EU approval to buy Viatris's OTC business, with required divestments in certain European countries.
- Témoignage du CIO de Cooper Consumer Health : le SOC au cœur de la réduction des risques cyber
Cooper Consumer Health's CIO highlights how a Security Operations Center is central to reducing cyber risks and improving incident response.
- Comment CVC a permis à Cooper de doubler de taille avec le portefeuille de Viatris
Cooper, backed by CVC, is set to double its size by acquiring Viatris's OTC portfolio for $2.17 billion, with the deal closing expected in mid-2024.
- Cooper avale des médicaments sans ordonnance
Cooper Consumer Health is preparing a transformative acquisition involving 200 OTC products or entities, expanding its selfcare portfolio.
- PwC sur l'acquisition envisagée par Cooper Consumer Health du portefeuille de produit OTC de Viatris
PwC performed comprehensive due diligence for Cooper Consumer Health's planned acquisition of Viatris' OTC product portfolio.
- | BeautyMatter
Cooper Consumer Health is acquiring French gummy supplement maker Lashilé Beauty to expand its health product portfolio and digital reach.
- Cooper Consumer Health appoints Bart Meermans as CEO and the acquisition of Lashilé Beauty
Cooper Consumer Health appointed Bart Meermans as CEO and agreed to acquire French supplement maker Lashilé Beauty to boost growth and expand its self-care product range.
- Charterhouse Capital Partners entre en négociations exclusives pour la cession de Cooper Consumer Health
Charterhouse is negotiating to sell a majority stake in Cooper Consumer Health to CVC, with plans for joint reinvestment to continue expanding the OTC medicines business internationally.
- Cooper se prescrit un LBO bis
Cooper, a major European OTC drug maker, is undergoing a second leveraged buyout with a new foreign financial investor replacing Charterhouse.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Cooper Consumer Health?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies